[HTML][HTML] Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell …

N Nakamura, Y Arai, T Kitawaki, T Jo… - British Journal of …, 2023 - ncbi.nlm.nih.gov
CD19-targeted chimeric antigen receptor T cell (CAR-T) therapy is an innovative treatment 1
for patients with diffuse large B-cell lymphoma (DLBCL). CAR-T-specific complications have …

Osteopontin regulates phosphate solubility to prevent mineral aggregates in CKD

JD Imig - Kidney360, 2022 - journals.lww.com
CKD is a significant health care burden that afflicts 10% of the world population (1).
Progression of CKD includes tubular epithelial cell injury, renal inflammation, and fibrosis (2 …